Green View Magazine | December 2019

26 GREEN VIEW MAGAZINE DECEMBER 2019 AT A GLANCE CANNABICS PHARMACEUTICALS INC. WHAT: U.S. public company developing cannabinoid-based therapies for cancer WHERE: Bethesda, Maryland; Tel-Aviv and Rehovot, Israel WEBSITE: A necdotally, it is well known that cannabis has the potential to kill cancer cells. It is also well known that no two people have the same genetic makeup. Finding the best possible match became the challenge for Cannabics Pharmaceuticals Inc. (CNBX). By introducing Cannabinoids to Modern Precision Medicine through personalized assessment tools, Cannabics is helping to move cannabinoids into the future of cancer therapy. Bringing the promises of the healing power of cannabis to cancer patients today. This amazing work is being undertaken by a dedicated group of experts at the Cannabics Pharmaceuticals U.S. Head Office in Bethesda, Maryland, and Israeli locations in Tel-Aviv (Corporate Offices) and Rehovot (Lab). Business View recently asked the Cannabics team about the company’s operations, biggest challenges, and how they plan to achieve their passionate mission to advance cancer treatment options. The following is an edited transcript of their responses: armaceuticals Inc. THE HEALING POWER OF CANNABIS INVESTMENT